Delivery Order SPE2DB24D8001-SPE2DB24FKYWE
Award Date
8/6/24
Potential Completion Date
8/7/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business. The contract is for the delivery of Orencia 125 mg/ml syringes, a pharmaceutical product. The contract has a firm fixed price of $7,098.20 and a period of performance extending to March 10, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that allows the company to provide a range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, valued at $10,206.57, is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This contract has a performance period extending through September 20, 2023 and is a firm fixed-price delivery order with no set-aside designation. Dakota Drug, Inc. holds a significant single-award Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ORENCIA 125 MG/ML syringes. The $5,004.06 firm-fixed-price contract has an ultimate completion date of October 31, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a significant single-award Indefinite...
This is a $23,856.51 firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) to provide Orencia Clickject 125 mg/ml medication. The delivery order has a completion date of July 10, 2024. Dakota Drug, Inc. is an experienced federal contractor that has supplied a wide range of pharmaceutical products and medical supplies to the DLA Troop Support Medical for over two decades. This delivery order does not have...
The Defense Logistics Agency (DLA) awarded a $6,192.13 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of ORENCIA 125 MG/ML syringes. This award is under Dakota Drug, Inc.'s existing $999,999,999.00 Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. The...
The Defense Logistics Agency (DLA) awarded a $3,765.27 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Orencia ClickJect 125 mg/ml autoinjectors. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug with DLA Troop Support Medical for a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,224.96 contract is for the delivery of ORENCIA 125 MG/ML SYRINGE/ML, a biologic drug used to treat autoimmune conditions. The contract has an ultimate completion date of May 13, 2024 and was awarded on May 10, 2024 without a set-aside designation. Dakota Drug,...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...
This is a firm fixed price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,146.59 contract is for the supply of Orencia 125 mg/ml syringes to support military treatment facilities in Minot, North Dakota. Dakota Drug, Inc. provides a range of pharmaceutical products and medical consumables to the Department of Defense (DOD) under its DLA Troop Support Medical blanket purchase...
This is a delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) to provide ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The contract has a ceiling value of $6,588.71 and a period of performance through November 20, 2024. Dakota Drug, Inc. holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to efficiently deliver a wide...